Cargando…
Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve
BACKGROUND: The balloon-expandable SAPIEN 3 (S3) is superior to the older-generation balloon-expandable SAPIEN XT (XT) in a lower incidence of paravalvular aortic regurgitation, lower complication rates and better survival in transcatheter aortic valve implantation (TAVI). However, prosthesis–patien...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978259/ https://www.ncbi.nlm.nih.gov/pubmed/33737333 http://dx.doi.org/10.1136/openhrt-2020-001531 |
_version_ | 1783667173874466816 |
---|---|
author | Miyasaka, Masaki Tada, Norio Taguri, Masataka Kato, Shigeaki Enta, Yusuke Hata, Masaki Watanabe, Yusuke Naganuma, Toru Yamawaki, Masahiro Yamanaka, Futoshi Shirai, Shinichi Ueno, Hiroshi Mizutani, Kazuki Tabata, Minoru Takagi, Kensuke Yamamoto, Masanori Hayashida, Kentaro |
author_facet | Miyasaka, Masaki Tada, Norio Taguri, Masataka Kato, Shigeaki Enta, Yusuke Hata, Masaki Watanabe, Yusuke Naganuma, Toru Yamawaki, Masahiro Yamanaka, Futoshi Shirai, Shinichi Ueno, Hiroshi Mizutani, Kazuki Tabata, Minoru Takagi, Kensuke Yamamoto, Masanori Hayashida, Kentaro |
author_sort | Miyasaka, Masaki |
collection | PubMed |
description | BACKGROUND: The balloon-expandable SAPIEN 3 (S3) is superior to the older-generation balloon-expandable SAPIEN XT (XT) in a lower incidence of paravalvular aortic regurgitation, lower complication rates and better survival in transcatheter aortic valve implantation (TAVI). However, prosthesis–patient mismatch (PPM) more frequently occurs in S3 than XT. Further, little information is available on PPM after TAVI using S3 in Asians. This study aims to determine the incidence and predictors of PPM in S3 by focusing on the difference between S3 and XT using data from a Japanese multicentre registry. METHODS: From the Optimised transCathEter vAlvular iNtervention-TAVI (OCEAN-TAVI) registry, 2134 patients undergoing TAVI using S3 or XT were included. PPM was defined as moderate if ≧0.65 but ≦0.85 cm(2)/m(2) or severe if <0.65 cm(2)/m(2) at the indexed effective orifice area by postprocedural echocardiography. RESULTS: The incidence of moderate and severe PPM in S3 was 13.3% and 1.3%, respectively. The 20 mm transcatheter heart valve (THV) was more frequently used in S3 than XT (7.4% vs 2.4%, p<0.0001). PPM was more frequently observed in S3 than XT (14.7% vs 8.8%, p<0.0001). Multivariate logistic regression analysis revealed S3 predicted PPM (OR 1.92 (95% CI 1.35 to 2.74), p=0.0003). The mutual predictors for PPM between S3 and XT were younger age, larger body surface area, smaller aortic valve area, no balloon postdilatation and the use of 20 mm and 23 mm THV. When comparing 23 mm, 26 mm and 29 mm S3, the ORs of 20 mm S3 were 5.67 (95% CI 2.88 to 11.12), 19.24 (95% CI 8.13 to 46.86) and 51.03 (95% CI 12.28 to 280.77), respectively. CONCLUSIONS: The incidence of PPM after TAVI using S3 was 14.6% overall in this Asian population. PPM was more frequently observed in S3 than XT. A considerable number of patients were treated by the 20 mm S3 in an Asian cohort. The 20 mm THV was identified as a strong predictor for PPM. |
format | Online Article Text |
id | pubmed-7978259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-79782592021-03-30 Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve Miyasaka, Masaki Tada, Norio Taguri, Masataka Kato, Shigeaki Enta, Yusuke Hata, Masaki Watanabe, Yusuke Naganuma, Toru Yamawaki, Masahiro Yamanaka, Futoshi Shirai, Shinichi Ueno, Hiroshi Mizutani, Kazuki Tabata, Minoru Takagi, Kensuke Yamamoto, Masanori Hayashida, Kentaro Open Heart Valvular Heart Disease BACKGROUND: The balloon-expandable SAPIEN 3 (S3) is superior to the older-generation balloon-expandable SAPIEN XT (XT) in a lower incidence of paravalvular aortic regurgitation, lower complication rates and better survival in transcatheter aortic valve implantation (TAVI). However, prosthesis–patient mismatch (PPM) more frequently occurs in S3 than XT. Further, little information is available on PPM after TAVI using S3 in Asians. This study aims to determine the incidence and predictors of PPM in S3 by focusing on the difference between S3 and XT using data from a Japanese multicentre registry. METHODS: From the Optimised transCathEter vAlvular iNtervention-TAVI (OCEAN-TAVI) registry, 2134 patients undergoing TAVI using S3 or XT were included. PPM was defined as moderate if ≧0.65 but ≦0.85 cm(2)/m(2) or severe if <0.65 cm(2)/m(2) at the indexed effective orifice area by postprocedural echocardiography. RESULTS: The incidence of moderate and severe PPM in S3 was 13.3% and 1.3%, respectively. The 20 mm transcatheter heart valve (THV) was more frequently used in S3 than XT (7.4% vs 2.4%, p<0.0001). PPM was more frequently observed in S3 than XT (14.7% vs 8.8%, p<0.0001). Multivariate logistic regression analysis revealed S3 predicted PPM (OR 1.92 (95% CI 1.35 to 2.74), p=0.0003). The mutual predictors for PPM between S3 and XT were younger age, larger body surface area, smaller aortic valve area, no balloon postdilatation and the use of 20 mm and 23 mm THV. When comparing 23 mm, 26 mm and 29 mm S3, the ORs of 20 mm S3 were 5.67 (95% CI 2.88 to 11.12), 19.24 (95% CI 8.13 to 46.86) and 51.03 (95% CI 12.28 to 280.77), respectively. CONCLUSIONS: The incidence of PPM after TAVI using S3 was 14.6% overall in this Asian population. PPM was more frequently observed in S3 than XT. A considerable number of patients were treated by the 20 mm S3 in an Asian cohort. The 20 mm THV was identified as a strong predictor for PPM. BMJ Publishing Group 2021-03-18 /pmc/articles/PMC7978259/ /pubmed/33737333 http://dx.doi.org/10.1136/openhrt-2020-001531 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Valvular Heart Disease Miyasaka, Masaki Tada, Norio Taguri, Masataka Kato, Shigeaki Enta, Yusuke Hata, Masaki Watanabe, Yusuke Naganuma, Toru Yamawaki, Masahiro Yamanaka, Futoshi Shirai, Shinichi Ueno, Hiroshi Mizutani, Kazuki Tabata, Minoru Takagi, Kensuke Yamamoto, Masanori Hayashida, Kentaro Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve |
title | Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve |
title_full | Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve |
title_fullStr | Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve |
title_full_unstemmed | Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve |
title_short | Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve |
title_sort | incidence and predictors of prosthesis–patient mismatch after tavi using sapien 3 in asian: differences between the newer and older balloon-expandable valve |
topic | Valvular Heart Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978259/ https://www.ncbi.nlm.nih.gov/pubmed/33737333 http://dx.doi.org/10.1136/openhrt-2020-001531 |
work_keys_str_mv | AT miyasakamasaki incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT tadanorio incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT tagurimasataka incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT katoshigeaki incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT entayusuke incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT hatamasaki incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT watanabeyusuke incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT naganumatoru incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT yamawakimasahiro incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT yamanakafutoshi incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT shiraishinichi incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT uenohiroshi incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT mizutanikazuki incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT tabataminoru incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT takagikensuke incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT yamamotomasanori incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT hayashidakentaro incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve AT incidenceandpredictorsofprosthesispatientmismatchaftertaviusingsapien3inasiandifferencesbetweenthenewerandolderballoonexpandablevalve |